The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer (NSCLC).
 
Heather A. Wakelee
No Relationships to Disclose
 
Nasser K. Altorki
No Relationships to Disclose
 
Caicun Zhou
No Relationships to Disclose
 
Tibor Csőszi
No Relationships to Disclose
 
Ihor O. Vynnychenko
No Relationships to Disclose
 
Oleksandr Goloborodko
No Relationships to Disclose
 
Alexander Luft
No Relationships to Disclose
 
Andrey Akopov
No Relationships to Disclose
 
Alex Martinez-Marti
No Relationships to Disclose
 
Hirotsugu Kenmotsu
No Relationships to Disclose
 
Yuh-Min Chen
No Relationships to Disclose
 
Antonio Chella
No Relationships to Disclose
 
Shunichi Sugawara
No Relationships to Disclose
 
Barbara J. Gitlitz
No Relationships to Disclose
 
Elizabeth Bennett
No Relationships to Disclose
 
Fan Wu
No Relationships to Disclose
 
Jing Yi
No Relationships to Disclose
 
Yu Deng
No Relationships to Disclose
 
Mark McCleland
No Relationships to Disclose
 
Enriqueta Felip
No Relationships to Disclose